Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness

Nicole Cyrille, Pedro Villablanca, Harish Ramakrishna

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.

Original languageEnglish (US)
Pages (from-to)214-216
Number of pages3
JournalAnnals of cardiac anaesthesia
Volume19
Issue number2
DOIs
StatePublished - Apr 1 2016

Keywords

  • Biomarkers
  • Cardiovascular disease
  • Critical illness
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness'. Together they form a unique fingerprint.

Cite this